Breaking News, Financial News

Financial Report: PDI, Inc.

Sales services segment revenue for the quarter was $41.4 million (+97%) and for the year was $133.3 million (+82%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PDI, Inc.

4Q Revenues: $44.7 million (+94%)

4Q Loss:
$2.6 million (loss of $18.4 million in 4Q09)

FY Revenues: $144.7 million (+80%)

FY Loss: $6.8 million (loss of $33.6 million FY09)

Comments: Sales services segment revenue for the quarter was $41.4 million (+97%) and for the year was $133.3 million (+82%). Marketing services revenue for the quarter was $3.3 million and for the year was $11.3 million, down slightly compared to 2009. Results for the quarter includes a $3.1 million operating loss related to the Group DCA acquisition, and for the year includes the operating loss of $4.3 million, comprised of a $0.5 million from legacy PDI and a $3.8 million from the Group DCA acquisition.@font-face { font-family: “Cambria”; }@font-face { font-family: “Optima”; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: “Times New Roman”; }div.Section1 { page: Section1; }

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters